Services

Discovery Chemistry
Synthetic Chemistry
Library Chemistry Peptide Chemistry Carbohydrate Chemistry Nucleic Acid Chemistry PROTAC Chemistry
Medicinal Chemistry
Computer-Aided Drug Design (AIDD)
Scale Up
Proven synthetic routes and computational modeling accelerate molecule design from hit to clinical candidate with unmatched scale.
Biologics Discovery
Antibody Discovery and Engineering
B Cell Cloning Hybridoma Phage Display Fully Human Therapeutic mAb Discovery Affinity Maturation Featured Services
Antibody Drug Conjugate (ADC) Development
Protein Production
Drug Developability / Manufacturability Study Integrated Biologics Developability Developability Assessment
Reliable antibody discovery and protein engineering deliver high-affinity therapeutics through flexible, integrated platforms.
Translational Biology
Molecular Biology
shRNA-Mediated Target Gene Knockdown and Stable Cell Line Generation siRNA Mediated Target Gene Knockdown CRISPR-Cas9-Mediated Target Gene Knockout
Biochemistry
Analytical Screening and Services

  • Biologics Analytical Services
  • High-Throughput Screening (HTS)
  • Analytical Services
  • Epitope Binning
Structure and Interaction Analysis

  • Biomolecular Interaction Analysis
  • Peptide-Large Molecule Interaction Studies
  • Affinity Determination of Antibody Derivatives/Antigens
  • Protein Structure
Development Packages and Testing

  • Analytical Development and Testing
  • ADC Release and Stability Testing
  • CMC Biologics Analytical Development and Testing
  • Complete Analytical Development Packages with mAb/ADC
Harmonization
In Vitro Pharmacology
Immune Cell Assays

  • Primary Immune Cell Assays
  • Th Subsets Differentiation Assays
  • Mixed Lymphocyte Reaction (MLR) Assay
  • T Cells Total CD4/CD8 Activation and Proliferation Assays
  • Whole Blood/PBMC Stimulation and Cytokine Release Assay
Functional and Cell Assays

  • Cell Functional Assays
  • Cell Signaling Assays
  • Functional Assay Panels
  • In Vitro Electrophysiology and Ex Vivo Assays
  • Cancer Cell Line Panel Screen
Target-Specific Assays

  • Radiometric
  • Ubiquitin/PROTAC
  • Kinases
  • Epigenetics
  • KRAS
  • COVID-19
  • Antibody Target Specific Assays
  • Small Molecule Target Specific Assays
Custom Development and Safety

  • MOA Study
  • Pharmacology Safety Panel
  • GPCR/NR/Ion Channel/Transporter
  • Customized Assay Development
  • Comprehensive In Vitro Proarrhythmia Assay (CiPA)
In Vivo Pharmacology
Immune Disease Models

  • Immunology and Inflammation
  • Autoimmune Disease and Inflammation Models
  • Adjuvant-Induced Arthritis in Rats
  • Imiquimod (IMQ)-Induced Psoriasis in Mice
  • Systemic Inflammation in Mice
Oncology and Immunooncology Models

  • Oncology
  • Immuno-Oncology
  • Model Generation Study in CDX
  • CDX Models
  • TIL Subpopulation Screening in Syngeneic Models
Neuroscience

  • Neuroscience
  • Behavioral Pharmacology
Analysis Platforms

  • Ex vivo Analysis Platforms
  • Multi-Color Flow Cytometry
  • Luminex
ADME (PK-PD) and Exploratory Tox
Bioanalysis and Pharmacokinetics

  • Immunogenicity
  • PK/PD Study in Tumor-Bearing Animal
  • Biomarkers, Preclinical & Clinical Sample Analysis
  • Pharmacokinetics
  • Bioanalysis
  • In Vitro ADME
Large Molecule Services

  • Large Molecule PK/BA Services
  • Antibody-Drug Conjugate (ADC)
  • Monoclonal Antibodies
  • Bispecific Antibodies
  • Proteins and Peptides
Pathology

  • Histopathology
  • Immunohistochemistry (IHC)
  • Immunohistochemistry (IHC)
GLP Tox
Precise target validation and pharmacological assays bridge discovery to development, enabling faster breakthroughs.
Bioprocess Development
Cell Line and Process Development
Stable Cell Line Developement Process Development Cell Line Development and Banking
Scale Up-Biologics
Formulation and Development

  • Formulation Development
  • Manufacturing Process Development
Production and Manufacturing

  • Aseptic Filling and Freeze Drying
  • Pilot Scale Production
  • cGMP Manufacturing
  • GMP Production
Safety and Compliance Studies

  • Extractables and Leachables
  • Final Container Extractables & Leachables Study
Scalable cell line engineering
and GMP manufacturing optimize biologics production for seamless clinical
progression.
Drug Discovery Journey

About ChemPartner

About ChemPartner Global Locations

Resources

News & Events Blogs & White Papers Webinars Publications

Contact Us

Start Your Project

Services

About ChemPartner

Resources

Contact Us

I need a

choose

Target ID Hit-to-Lead Lead Optimization Pre-clinical IND
study
on

modality

Small Molecule Biologics Protein Peptides Targeted Protein Degradation Oligonucleotides Therapeutic Antibody Development Antibody Drug Conjugates Pro Drugs
for

disease area

Oncology Immunology Neuroscience Other
GO
This website uses cookies
This website uses cookies to improve your experience while you navigate through the website.

Book a Consultation

CMC Biologics Analytical Development and Testing
ServicesTranslational BiologyBiochemistryCMC Biologics Analytical Development and Testing
CMC Biologics Analytical Development and Testing

ChemPartner’s analytical capability includes analytical development testing for non-GMP samples, GMP drug substances, and drug product release and stability testing as well as extended product characterization. 

Our rapidly growing analytical development and quality control team is comprised of 50+ scientists (60%+ with PhD or MS degrees) with the combined experience of 100+ years in analytical development and 70+ years in cGMP. 

We offer a broad range of analytical services using state-of-the-art analytical instruments for our clients in preclinical and clinical development as well as commercial production. We are capable of developing all types of analytical methods for therapeutic proteins, including, but not limited to, monoclonal antibodies, recombinant proteins, antibody drug conjugates, and peptides for testing their general quality, identity, purity, impurity, potency, and microbiological testing. Our analytical team also supports regulatory submissions (IND or NDA) by providing the required product physicochemical characterization, analytical comparability studies, technical writing, and documentation.

Major analytical capabilities include:

  • Characterization & physicochemical analysis
    • Molecular weight 
    • Amino acid sequence
    • PTM (deamidation, oxidation, others) 
    • Disulfide bond 
    • Free Sulfhydryl group
    • Sialic acid   
    • N/C terminal heterogeneity 
    • N-terminal sequencing
    • N-glycan, O-glycan site and occupancy 
    • Secondary structure 
    • Tertiary structure 
    • Charge  
    • Size  
    • Aggregation 
    • Thermal & Colloid stability
    • Binding affinity 

Product release testing includes:

  • General Quality
    • Appearance
    • pH 
    • Protein Content
    • Weight Variation
    • Visible and Sub-visible particles
    • Moisture Determination
    • Osmolality
    • Excipients 
  • Physicochemical Property
    • Charge heterogeneity/pI 
    • Monomer/aggregates/fragments
    • Molecular weight/size heterogeneity
    • N-glycan analysis
    • Sialic acid analysis
    • Peptide mapping
  • Microbial Analysis
    • Endotoxin
    • Sterility
    • Bioburden                           
  • Activity & Potency Analysis
    • ELISA
    • ADCC/CDC/FACS
    • Reporter gene assays
    • Other cell-based assays          
  • Process Impurity
    • HCP 
    • Leached Protein A 
    • Host cell DNA
    • Other process impurities
Your Trusted Partner Starts Here
Let’s talk. We’ll reach out immediately to understand how we can help.
Begin Your Journey

News & Events

See All News & Events
Join us in San Diego at SOT 2026!
Mar 23, 2026
Join us in San Diego at SOT 2026!
Join us in Atlanta for ACS 2026!
Mar 23, 2026
Join us in Atlanta for ACS 2026!
Join us at AACR 2026 in San Diego!
Mar 22, 2026
Join us at AACR 2026 in San Diego!
Thank you for joining us at World ADC London 2026.
Mar 22, 2026
Thank you for joining us at World ADC London 2026.

Blog

See All Blog
Technical Spotlight: Pre-Clinical Models for Multiple Sclerosis
Mar 12, 2026
Technical Spotlight: Pre-Clinical Models for Multiple Sclerosis
White Paper: Accelerate IL-23 Drug Development with Translational Psoriasis Models
Mar 5, 2026
White Paper: Accelerate IL-23 Drug Development with Translational Psoriasis Models
More Than the Sum of Parts: Dual-Payload ADCs and the Art of DAR Optimization
Jan 28, 2026
More Than the Sum of Parts: Dual-Payload ADCs and the Art of DAR Optimization
Unlocking New Targets: Cytokine Receptor Platform for Immunology Innovation
Jan 15, 2026
Unlocking New Targets: Cytokine Receptor Platform for Immunology Innovation

Our Services

Our Company

Resources

Careers

Publications

Locations

Investor Relations

China: +86 21 5132 0088
Business Inquiries: Ext. 3436

US: +1 617 415 6979

Europe: +45 4586 9000

contact@chempartner.com

©2026 ChemPartner

Privacy Policy